Jason R. Brown

562 total citations
29 papers, 404 citations indexed

About

Jason R. Brown is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, Jason R. Brown has authored 29 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in Jason R. Brown's work include Force Microscopy Techniques and Applications (6 papers), Cardiac pacing and defibrillation studies (5 papers) and Mechanical and Optical Resonators (5 papers). Jason R. Brown is often cited by papers focused on Force Microscopy Techniques and Applications (6 papers), Cardiac pacing and defibrillation studies (5 papers) and Mechanical and Optical Resonators (5 papers). Jason R. Brown collaborates with scholars based in United States, Canada and Ireland. Jason R. Brown's co-authors include Boris B. Akhremitchev, Chad Ray, Cynthia Bruyns, J.-C. Latombe, Stephen Sorkin, Kevin Montgomery, Michael Stephanides, Andrea Kirkpatrick, Steven M. Thornberg and James Michael Hochrein and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and The Journal of Physical Chemistry B.

In The Last Decade

Jason R. Brown

24 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason R. Brown United States	11	143	74	56	53	51	29	404
Akihiro MATSUDA Japan	16	59 0.4×	113 1.5×	64 1.1×	133 2.5×	36 0.7×	85	626
Weixi Chen China	16	173 1.2×	369 5.0×	37 0.7×	41 0.8×	12 0.2×	78	653
Matt Gordon United States	13	85 0.6×	203 2.7×	65 1.2×	69 1.3×	30 0.6×	73	653
Hiroki Ishida Japan	15	52 0.4×	151 2.0×	18 0.3×	108 2.0×	120 2.4×	64	616
Astrid Aksnes Norway	11	74 0.5×	234 3.2×	36 0.6×	173 3.3×	12 0.2×	52	422
Meng Shi China	12	146 1.0×	144 1.9×	57 1.0×	145 2.7×	13 0.3×	68	458
Hiromi Katoh Japan	12	64 0.4×	276 3.7×	14 0.3×	62 1.2×	43 0.8×	42	688
Kaihua Wei China	14	181 1.3×	255 3.4×	25 0.4×	189 3.6×	16 0.3×	39	701
Jan Hošek Czechia	8	115 0.8×	17 0.2×	22 0.4×	317 6.0×	30 0.6×	33	662

Countries citing papers authored by Jason R. Brown

Since Specialization

Citations

This map shows the geographic impact of Jason R. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason R. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason R. Brown more than expected).

Fields of papers citing papers by Jason R. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason R. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason R. Brown. The network helps show where Jason R. Brown may publish in the future.

Co-authorship network of co-authors of Jason R. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Jason R. Brown. A scholar is included among the top collaborators of Jason R. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason R. Brown. Jason R. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsai, Frank, Michael J. Birrer, Jason R. Brown, et al.. (2024). A phase 2 clinical trial of first-in-class fascin inhibitor NP-G2-044 as monotherapy and in combination therapy with anti-PD-1 immunotherapy in patients with advanced solid tumor malignancies.. Journal of Clinical Oncology. 42(16_suppl). 3112–3112. 2 indexed citations

Koshkin, Vadim S., Matthew T. Campbell, Alexandra Drakaki, et al.. (2024). 1967MO Preliminary efficacy and safety of disitamab vedotin (DV) with pembrolizumab (P) in treatment (Tx)-naive HER2-expressing, locally advanced or metastatic urothelial carcinoma (la/mUC): RC48G001 cohort C. Annals of Oncology. 35. S1138–S1139. 11 indexed citations

Brown, Jason R., John S. Schwartz, Michael E. Essington, et al.. (2024). The role of dissolved organic carbon in Great Smoky Mountains National Park streams impacted by long-term acid deposition. Environmental Monitoring and Assessment. 196(11). 1096–1096.

Brown, Jason R. & Vadim S. Koshkin. (2024). Therapies After Progression on Enfortumab Vedotin and Pembrolizumab: Navigating Second-line Options for Metastatic Urothelial Carcinoma in the New Treatment Landscape. European Urology Focus. 10(2). 231–233. 5 indexed citations

Jiang, C.-Y., Omar Alhalabi, An‐Soo Jang, et al.. (2024). 1988P Enfortumab vedotin (EV) + pembrolizumab (P) outcomes outside clinical trials and biomarkers of benefit in patients (pts) with advanced urothelial carcinoma: Analysis of the UNITE study. Annals of Oncology. 35. S1149–S1150. 3 indexed citations

Jang, An‐Soo, Chenyu Jiang, Amanda Nizam, et al.. (2024). 1989P Efficacy of enfortumab vedotin (EV) in patients (pts) with (w) advanced urothelial carcinoma (aUC) who have baseline neuropathy (N) and/or diabetes mellitus (DM): A UNITE study analysis. Annals of Oncology. 35. S1150–S1151.

Bharmi, Rupinder, Ziad F. Gellad, Jason R. Brown, et al.. (2023). Real World Characterization of Chronic Pain, Success Rates and Implant Rates: Evidence from a Digital Health Platform of Patients Undergoing Spinal Cord Stimulation Evaluations. Journal of Pain. 24(12). 2228–2239.

Zhang, Shumin, Chantal E. Holy, Gary Eichenbaum, et al.. (2021). Carcinogenic assessment of cobalt-containing alloys in medical devices or cobalt in occupational settings: A systematic review and meta-analysis of overall cancer risk from published epidemiologic studies. Regulatory Toxicology and Pharmacology. 125. 104987–104987. 10 indexed citations

Holy, Chantal E., Shumin Zhang, Laura Perkins, et al.. (2021). Site-specific cancer risk following cobalt exposure via orthopedic implants or in occupational settings: A systematic review and meta-analysis. Regulatory Toxicology and Pharmacology. 129. 105096–105096. 12 indexed citations

10.

Brown, Jason R., Álvaro Alonso, Sula Mazimba, Eduardo N. Warman, & Kenneth C. Bilchick. (2020). Improved 30 day Heart Failure Rehospitalization Prediction through the Addition of Device-Measured Parameters. ESC Heart Failure. 7(6). 3762–3771. 4 indexed citations

11.

Brown, Jason R., Álvaro Alonso, Eduardo N. Warman, & Kenneth C. Bilchick. (2017). Long-term impact of intrathoracic impedance findings on survival and heart failure hospitalizations after cardiac resynchronization therapy in ICD Registry patients. EP Europace. 20(7). 1138–1145. 5 indexed citations

12.

Krahn, Andrew D., et al.. (2016). Impact of generator replacement on the risk of Fidelis lead fracture. Heart Rhythm. 13(8). 1618–1623. 2 indexed citations

13.

Brown, Jason R., Kenneth C. Bilchick, Álvaro Alonso, & Eduardo N. Warman. (2015). OptiVol Impedance Threshold Crossing Predicts Patients with Higher Mortality or Hospitalization Risk Among Medicare Recipients. Journal of Cardiac Failure. 21(8). S122–S122. 1 indexed citations

14.

Ray, Chad, Senli Guo, Jason R. Brown, Nan Li, & Boris B. Akhremitchev. (2010). Kinetic Parameters from Detection Probability in Single Molecule Force Spectroscopy. Langmuir. 26(14). 11951–11957. 5 indexed citations

15.

Gomadam, Parthasarathy, Jason R. Brown, E.R. Scott, & Craig Schmidt. (2009). Predicting charge-times of implantable cardioverter defibrillators. PubMed. 2009. 3020–3023. 1 indexed citations

16.

Ray, Chad, Chao Gu, Jason R. Brown, Andrea Kirkpatrick, & Boris B. Akhremitchev. (2008). Anisotropy of Pairwise Interactions between Hexadecanes in Water Measured by AFM Force Spectroscopy. The Journal of Physical Chemistry C. 112(46). 18164–18172. 5 indexed citations

17.

Gomadam, Parthasarathy, et al.. (2007). Predicting Charge-Times of Internal Cardioverter Defibrillators. ECS Transactions. 6(5). 15–23. 1 indexed citations

18.

Bernstein, Robert, Steven M. Thornberg, Roger A. Assink, et al.. (2007). The origins of volatile oxidation products in the thermal degradation of polypropylene, identified by selective isotopic labeling. Polymer Degradation and Stability. 92(11). 2076–2094. 27 indexed citations

19.

Thornberg, Steven M., Robert Bernstein, Daniel M. Mowery, et al.. (2006). Insights into Oxidation Pathways, from Gaseous Products of Polypropylene with Selective Isotopic Labeling. Macromolecules. 39(17). 5592–5594. 14 indexed citations

20.

Brown, Jason R., Stephen Sorkin, Cynthia Bruyns, et al.. (2002). Real-time simulation of deformable objects: tools and application. 228–258. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact